Schizophrenia trials in Germany

In Germany 21 Also abroad 489

19 of 21 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Evenamide in patients with treatment-resistant schizophrenia not responding to antipsychotics
Where
Aachen, Frankfurt Am Main, Mainz, Munich
Age
18 years and over
People
135 worldwide
Run by
Newron Pharmaceuticals S.p.A.
See details and how to join2024-519836-18-00
Phase 3Taking people
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Where
Erbach, Frankfurt Am Main
Age
55 years to 90 years
People
406 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00
Phase 3Taking people
Stratification and Treatment in Early Psychosis Study - ENHANCE
Where
Augsburg, Berlin, Cologne, Munich
Age
16 years to 40 years
People
250 worldwide
Run by
University of Oxford
See details and how to joinNCT06778564 · EU 2025-521929-32-00
Phase 3Not yet taking people in Germany
Stratification and Treatment in Early Psychosis Study -ASSIST
Where
Berlin, Cologne, Munich
Age
16 years to 50 years
People
250 worldwide
Run by
University of Oxford
See details and how to joinNCT07326124
Phase 3Not yet taking people in Germany
Stratification and Treatment in Early Psychosis Study - PROMOTE
Where
Berlin, Cologne, Lübeck, München
Age
12 years to 35 years
People
586 worldwide
Run by
University of Oxford
See details and how to joinNCT07434973
No phaseTaking people
FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis
Where
Augsburg, Berlin, Cologne, Hamburg, Mannheim, Marburg, München
Age
16 years to 35 years
People
252
Run by
Stephanie Mehl
See details and how to joinNCT07645443
No phaseTaking people
Intermittent Theta-Burst Stimulation to Improve Negative Symptoms and Cognition in Schizophrenia
Where
Hanover
Age
18 years to 65 years
People
60
Run by
Hannover Medical School
See details and how to joinNCT06740747
No phaseTaking people
Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia
Where
Mannheim
Age
18 years to 65 years
People
140
Run by
Central Institute of Mental Health, Mannheim
See details and how to joinNCT03911726
No phaseTaking people
Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison
Where
Berlin
Age
18 years to 75 years
People
120
Run by
Charite University, Berlin, Germany
See details and how to joinNCT07265180
Phase 4Taking people
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
Where
Bonn, Munich
Age
16 years to 70 years
People
2,500 worldwide
Run by
Parnassia Groep
See details and how to joinNCT05656469 · EU 2023-509680-25-00
No phaseNot yet taking people in Germany
Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
Where
Mannheim, München
Age
18 years to 65 years
People
140 worldwide
Run by
Ludwig-Maximilians - University of Munich
See details and how to joinNCT07586150
No phaseTaking people
Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders
Where
Berlin
Age
18 years to 65 years
People
60
Run by
Charite University, Berlin, Germany
See details and how to joinNCT07455929
No phaseTaking people
Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders
Where
Berlin
Age
18 years to 65 years
People
60
Run by
Charite University, Berlin, Germany
See details and how to joinNCT07395206
No phaseTaking people
Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
Where
Aachen, Augsburg, Göppingen, Göttingen, Hanover, Heidelberg, Ingolstadt, Mainz, Mannheim, München, Saarbrücken, Siegen, Tübingen, Wiesloch
Age
18 years to 75 years
People
140
Run by
Central Institute of Mental Health, Mannheim
See details and how to joinNCT06456983
Phase 4Taking people
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Where
Augsburg, Bielefeld, Dortmund, Frankfurt am Main, Mainz, Muenster
Age
18 years to 70 years
People
418 worldwide
Run by
Dr. Inge Winter
See details and how to joinNCT05958875 · EU 2023-506602-39-00
No phaseTaking people
40 Hz Visual Stimulation as an Intervention in Schizophrenia
Where
Munich
Age
18 years and over
People
20
Run by
Technical University of Munich
See details and how to joinNCT06907420
No phaseTaking people
Yoga-based Group Intervention (YoGI) for In-patients With Schizophrenia Spectrum Disorders
Where
Steglitz
Age
18 years to 90 years
People
77
Run by
Charite University, Berlin, Germany
See details and how to joinNCT04730518
Phase 2Not yet taking people in Germany
Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity
Where
Augsburg, Munich
Age
18 years to 65 years
People
90
Run by
LMU Klinikum
See details and how to joinNCT06315972 · EU 2024-514457-30-00
No phaseTaking people
Effectiveness of Trauma Therapy Using Prolonged Exposure for Patients With PTSD and a Comorbid Psychotic Disorder
Where
Hamburg
Age
18 years and over
People
56
Run by
Medicalschool Hamburg
See details and how to joinNCT06048172